Select Publications
Book Chapters
2018, 'Mechanisms for Controlling HIV-1 infection: a Gene Therapy Approach', in In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders, http://dx.doi.org/10.5772/intechopen.72962
,Journal articles
2024, 'Current State of Therapeutics for HTLV-1', Viruses, 16, http://dx.doi.org/10.3390/v16101616
,2024, 'Advances in HIV Gene Therapy', International Journal of Molecular Sciences, 25, http://dx.doi.org/10.3390/ijms25052771
,2023, 'Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2', Antiviral Research, 217, http://dx.doi.org/10.1016/j.antiviral.2023.105677
,2023, 'Statement in Support of: "Virology under the Microscope - a Call for Rational Discourse"', mSphere, 8, http://dx.doi.org/10.1128/msphere.00165-23
,2023, 'Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”', mBio, 14, http://dx.doi.org/10.1128/mbio.00815-23
,2023, 'Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk', Frontiers in Immunology, 14, http://dx.doi.org/10.3389/fimmu.2023.1112513
,2023, 'Statement in Support of: “Virology under the Microscope-a Call for Rational Discourse”', Journal of Virology, 97, http://dx.doi.org/10.1128/jvi.00451-23
,2023, 'The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities', Clinical and Translational Immunology, 12, http://dx.doi.org/10.1002/cti2.1454
,2022, 'Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection', Pharmaceutics, 14, http://dx.doi.org/10.3390/pharmaceutics14071352
,2022, 'Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract', International Journal of Molecular Sciences, 23, http://dx.doi.org/10.3390/ijms23052408
,2022, 'Nanoscale probing and imaging of HIV-1 RNA in cells with a chimeric LNA-DNA sensor', Nanoscale, 14, pp. 3049 - 3061, http://dx.doi.org/10.1039/d1nr08418f
,2020, 'RNAi therapeutics: an antiviral strategy for human infections', Current Opinion in Pharmacology, 54, pp. 121 - 129, http://dx.doi.org/10.1016/j.coph.2020.09.011
,2020, 'Block and Lock HIV Cure Strategies to Control the Latent Reservoir', Frontiers in Cellular and Infection Microbiology, 10, http://dx.doi.org/10.3389/fcimb.2020.00424
,2019, 'The Role of Zinc in Antiviral Immunity', Advances in Nutrition, 10, pp. 696 - 710, http://dx.doi.org/10.1093/advances/nmz013
,2019, 'Delivery of gene therapy to resting immune cells for an HIV cure', Current Opinion in HIV and AIDS, 14, pp. 129 - 136, http://dx.doi.org/10.1097/COH.0000000000000531
,2018, 'RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency', Retrovirology, 15, pp. 67, http://dx.doi.org/10.1186/s12977-018-0451-0
,2018, 'Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34(+) cells in HIV-1 infection', AIDS, 32, pp. 1737 - 1747, http://dx.doi.org/10.1097/QAD.0000000000001882
,2018, 'Erratum: Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34R cells in HIV-1 infection (AIDS (2018) (2018) 32 (1737–1747) DOI: 10.1097/QAD.0000000000001882)', AIDS, 32, pp. 2857 - 2858, http://dx.doi.org/10.1097/01.aids.0000547984.16868.93
,2017, 'Zinc is a potent and specific inhibitor of IFN-λ3 signalling', Nature Communications, 8, http://dx.doi.org/10.1038/ncomms15245
,2016, 'Achieving HIV-1 control through RNA-directed gene regulation', Genes, 7, http://dx.doi.org/10.3390/genes7120119
,2016, 'The feasibility of incorporating Vpx into lentiviral gene therapy vectors', Molecular Therapy Methods and Clinical Development, 3, pp. 16066, http://dx.doi.org/10.1038/mtm.2016.66
,2015, 'Novel RNA duplex locks HIV-1 in a latent state via chromatin-mediated transcriptional silencing', Molecular Therapy Nucleic Acids, 4, pp. e261, http://dx.doi.org/10.1038/mtna.2015.31
,2015, 'Promoter targeting RNAs: Unexpected contributors to the control of HIV-1 transcription', Molecular Therapy Nucleic Acids, 4, pp. e222, http://dx.doi.org/10.1038/mtna.2014.67
,2015, 'Controlling HIV-1: Non-coding RNA gene therapy approaches to a functional cure', Frontiers in Immunology, 6, pp. 474, http://dx.doi.org/10.3389/fimmu.2015.00474
,2015, 'Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.', World Journal of Virology, 4, pp. 219 - 244, http://dx.doi.org/10.5501/wjv.v4.i3.219
,2013, 'Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing', Molecular Therapy Nucleic Acids, 2, pp. e137, http://dx.doi.org/10.1038/mtna.2013.64
,2012, 'Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression.', Journal of Immunology, 188, pp. 6238 - 6246, http://dx.doi.org/10.4049/jimmunol.1101196
,2012, 'Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinary in human cells', Nucleic Acids Research, 40, pp. 1579 - 1595, http://nar.oxfordjournals.org/content/40/4/1579
,2011, 'Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific', RNA Biology, 8, pp. 1035 - 1046, http://www.landesbioscience.com/journals/rnabiology/SuzukiRNA8-6.pdf
,2011, 'Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific.', RNA biology, 8, pp. 1035 - 1046
,2010, 'RNA duplexes in transcriptional regulation', Biomolecular Concepts, 1, pp. 285 - 296, http://dx.doi.org/10.1515/bmc.2010.021
,2010, 'Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: Implications for viral entry and immunogenicity', Journal of Virology, 84, pp. 2972 - 2982, http://dx.doi.org/10.1128/JVI.02151-09
,2006, 'Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination', Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 15987 - 15991, http://dx.doi.org/10.1073/pnas.0607564103
,2006, 'Varicella-Zoster virus ORF63 inhibits apoptosis of primary human neurons', Journal of Virology, 80, pp. 1025 - 1031, http://dx.doi.org/10.1128/JVI.80.2.1025-1031.2006
,2003, 'Varicella-Zoster Virus-Infected Human Sensory Neurons Are Resistant to Apoptosis, yet Human Foreskin Fibroblasts Are Susceptible: Evidence for a Cell-Type-Specific Apoptotic Response', Journal of Virology, 77, pp. 12852 - 12864, http://dx.doi.org/10.1128/JVI.77.23.12852-12864.2003
,Conference Papers
2020, 'RNA-DIRECTED EPIGENETIC SILENCING PROTECTS HUMANISED MICE DURING HIV CHALLENGE', in SEXUAL HEALTH, CSIRO PUBLISHING, pp. XXVII - XXVII, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000598625300036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'SEQUENCE SPECIFIC INDUCTION OF HIV-1 TRANSCRIPTIONAL GENE SILENCING TARGETING NF-kappa B SEQUENCES BY SIRNA WITHOUT ANY OFF-TARGET EFFECTS OF OTHER NF-kappa B DRIVEN GENES', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, pp. 425 - 425, presented at 7th Biennial Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, 04 May 2011 - 06 May 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297950900031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Abstracts
2023, 'Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types', in Molecular Pharmaceutics, Vol. 20, pp. 2039 - 2052, http://dx.doi.org/10.1021/acs.molpharmaceut.2c01030
,2021, 'RNA-directed gene therapy protects CD4+T cells during HIV challenge and delays virus rebound post-ART in humanized mice', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 24, pp. 10 - 10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713652900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Delivering Epigenetic Silencing Sirna to the Nucleus of Hiv-1 Infected Primary Activated Cd4+T-Cells via Nanoparticle System', in MOLECULAR THERAPY, CELL PRESS, ELECTR NETWORK, Vol. 28, pp. 468 - 469, presented at 23rd Annual Meeting of the American-Society-for-Gene-and-Cell-Therapy, ELECTR NETWORK, 12 May 2020 - 15 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530089302176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'RNA TARGETING PROMOTER REGION INHIBITS ACTIVATION OF LATENTLY INFECTED HIV-1', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Melbourne, Univ Coll, Parkville, Vol. 17, pp. 185 - 185, presented at 9th Biennial Meeting of the Australasian-Gene-and-Cell-Therapy-Society (AGCTS), AUSTRALIA, Univ Melbourne, Univ Coll, Parkville, 29 April 2015 - 01 May 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000362592700020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Patents
2020, Gene therapeutic for the treatment of HIV and uses thereof, Patent No. Germany, Spain, France, United Kingdom, Italy patent no. 3294895, https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20180321&CC=EP&NR=3294895A1&KC=A1
,Preprints
A Molecular Basis for the Increased Transmission of Ebolavirus in Recent Outbreaks, http://dx.doi.org/10.2139/ssrn.3507710
,